What explains the differences between centres in the European screening trial? A simulation study

類似資料

• Impact of PSA threshold and screening interval in prostate cancer screening outcomes – Comparing the Swedish and Finnish ERSPC centres
  著者:: Saarimäki, Lasse, 等
  出版事項: (2017)
• Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
  著者:: Carlsson, Sigrid V., 等
  出版事項: (2019)
• Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data
  著者:: Booth, Neill, 等
  出版事項: (2019)
• Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
  著者:: Talala, Kirsi, 等
  出版事項: (2020)
• A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
  著者:: Assel, Melissa, 等
  出版事項: (2017)